Top image

Staff at EMBL

Hongxing Hu

Postdoctoral Fellow
Merten Group

EMBL Heidelberg, Meyerhofstraße 1, 69117 Heidelberg, Germany

E-mail: send a mail

Publications

Total: 6 publication(s)

2014

Wang G, Zhou F, Buchy P, Zuo T, Hu H, Liu J, Song Y, Ding H, Tsai C, Chen Z, Zhang L, Deubel V, Zhou P. (2014)
DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin.
J. Infect. Dis. 209(5):676-685. doi:10.1093/infdis/jit414
Europe PMC | doi


2013

Qian M, Hu H, Zuo T, Wang G, Zhang L, Zhou P. (2013)
Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutinin.
J. Virol. 87(6):3571-3577. doi:10.1128/jvi.01292-12
Europe PMC | doi


2012

Wang L, Hu H, Yang J, Wang F, Kaisermayer C, Zhou P. (2012)
High yield of human monoclonal antibody produced by stably transfected Drosophila schneider 2 cells in perfusion culture using wave bioreactor.
Mol. Biotechnol. 52(2):170-179. doi:10.1007/s12033-011-9484-5
Europe PMC | doi

Hu H, Voss J, Zhang G, Buchy P, Zuo T, Wang L, Wang F, Zhou F, Wang G, Tsai C, Calder L, Gamblin SJ, Zhang L, Deubel V, Zhou B, Skehel JJ, Zhou P. (2012)
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
J. Virol. 86(6):2978-2989. doi:10.1128/jvi.06665-11
Europe PMC | doi


2010

Jiang H, Xu Y, Li L, Weng L, Wang Q, Zhang S, Jia B, Hu H, He Y, Jacob Y, Toyoda T. (2010)
Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.
Antivir. Chem. Chemother. 22(3):119-130. doi:10.3851/imp1902
Europe PMC | doi


2009

Tsai C, Caillet C, Hu H, Zhou F, Ding H, Zhang G, Zhou B, Wang S, Lu S, Buchy P, Deubel V, Vogel FR, Zhou P. (2009)
Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase.
Vaccine 27(48):6777-6790. doi:10.1016/j.vaccine.2009.08.056
Europe PMC | doi